Current anticancer treatments essentially target the primary tumor cells that proliferate quickly, but do not effectively ...

Metformin is a go-to diabetes drug, and researchers are looking at whether it can be used as a cancer-stopping supplement, ...

The resubmitted biologics license application for narsoplimab in transplant-associated thrombotic microangiopathy has been ...

Millions of Americans who receive intravenous treatment for multiple sclerosis, blood diseases and rheumatologic conditions ...

Treatment with cenobamate may reduce seizure frequency among patients with drug-resistant epilepsy after 3 months.

The table below is a review of notable updates that occurred in April 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage. Drug ...

The approved ALS therapy Radicava may cause serious unexpected side effects, such as liver problems and blood clots, per U.S. FDA data.

If phase 3 trials of MM120 (lysergide d-tartrate) for anxiety and depression are successful, could the LSD-based drug become ...

Sarepta has submitted a request to the FDA to include the death case in Elevidys’ label, and the agency plans to review the ...

A bill limiting when minors can consent to medical treatment without parental involvement passed the North Carolina House, ...

Cuts to the Substance Abuse and Mental Health Services Administration worry harm reductionists, while others are celebrating ...

A portable device that can instantly detect dangerous street drugs at extremely low concentrations has been developed at the ...